Quantum BioPharma News - August 14, 2026
🟢 Quantum BioPharma Surges 11.46% After Strong Q2 Results and FDA Clearance for Lucid-MS Phase 2
Quantum BioPharma is trading at $3.60 (+11.46%) today, following the release of robust Q2 2026 financial results and the recent FDA clearance for Lucid-MS to...
🟢 Quantum BioPharma is trading 5% up today after Q2 results and stronger liquidity
Quantum BioPharma is trading 5.11% up now at $3.40 after reporting second-quarter 2026 results and stronger liquidity on August 14, 2026. - Reported...
🟢 Quantum BioPharma is trading 7.43% up in pre-market after a 7.18% prior-session decline
Quantum BioPharma is trading at $3.47 (+7.43%) in pre-market, rebounding after a 7.18% decline on August 13. - No fresh company-specific announcement was...